Cognition Therapeutics, Inc. is a clinical stage neuroscience company which engages in developing drugs that help restore normal cellular damage responses in neurodegenerative and neuro-ophthalmic disorders. It offers the CT1812 which aims to restore the damaged cellular processes that drive diseases such as Alzheimer’s disease, dry age-related macular degeneration, geographic atrophy and other conditions. The company was founded by Franz F. Hefti, Gilbert M. Rishton, and Susan M. Catalano on August 21, 2007 and is headquartered in Purchase, NY.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
28
Frequently Asked Questions
What is Market Cap of Cognition Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Cognition Therapeutics Inc market cap is $142.04M.
What is the 52-week high for Cognition Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Cognition Therapeutics Inc 52 week high is $3.83 as of September 18, 2025.
What is the 52-week low for Cognition Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Cognition Therapeutics Inc 52 week low is $0.2223 as of September 18, 2025.
What is Cognition Therapeutics Inc stock price today?
Cognition Therapeutics Inc stock price today is $1.47.
What was Cognition Therapeutics Inc stock price yesterday?
Cognition Therapeutics Inc stock price yesterday was $1.61.
What is the PE ratio of Cognition Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Cognition Therapeutics Inc’s P/E ratio is -2.45.
What is the Price-to-Book ratio of Cognition Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Cognition Therapeutics Inc P/B ratio is 14.8799.
What is the 50-day moving average of Cognition Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Cognition Therapeutics Inc 50-day moving average is $1.44.
How many employess does Cognition Therapeutics Inc has?
